Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Electrochemotherapy versus standard radiotherapy for basal cell carcinoma
2016-002255-25Phase 2Active
- Sponsor
- Department of Oncology, Herlev Hospital
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bleomycin in basal cell carcinoma (BCC), sponsored by Department of Oncology, Herlev Hospital. Started Jun 2016; status: active.
02
Drugs
bleomycin
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on 2016-002255-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002255-25.